ViGenCell Inc. (KOSDAQ:308080)
South Korea · Delayed Price · Currency is KRW 9,500.00
-280.00 (-2.86%)
At close: Jun 5, 2026
ViGenCell Market Cap
ViGenCell has a market cap or net worth of 194.74 billion as of June 5, 2026. Its market cap has increased by 218.51% in one year.
Market Cap
194.74B
Enterprise Value
157.45B
Revenue
278.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
9,500.00
Market Cap Chart
Since August 25, 2021, ViGenCell's market cap has decreased from 561.23B to 194.74B, a decrease of -65.30%. That is a compound annual growth rate of -19.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 204.99B | 2.56% |
| Dec 30, 2025 | 199.87B | 315.01% |
| Dec 30, 2024 | 48.16B | -57.05% |
| Dec 28, 2023 | 112.12B | -17.15% |
| Dec 29, 2022 | 135.32B | -61.11% |
| Dec 30, 2021 | 347.95B | -38.00% |
| Aug 25, 2021 | 561.23B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kanaph Therapeutics | 278.88B |
| Kangstem Biotech | 253.48B |
| Y-Biologics | 225.39B |
| NIBEC | 223.72B |
| Genome & Company | 195.98B |
| TiumBio | 186.54B |
| Bio Solution | 180.37B |
| Ensol Biosciences | 172.98B |